Chief Scientific Officer - Early Drug Development

The Chief Scientific Officer - Early Drug Development will formulate and lead the company's global early-stage R&D strategy, establishing the R&D roadmap from target validation to proof-of-concept (POC). Responsibilities Lead the drug chemistry team and the biology team. Establish a global R&D layout and talent echelon for innovative drugs of Qilu. Plan and make decisions regarding the innovative drug pipeline, including cutting-edge technology fields such as small molecules, large molecules, ADCs, and small nucleic acids. Establish strategic partnerships with the global academic community, research institutions, and biotechnology companies to introduce cutting-edge technologies. Research on leadership mechanisms and formulate biomarker strategies to provide a solid scientific basis for R&D decisions. Qualifications Possess a doctoral degree in life sciences or a related medical field. Over 20 years of research and development experience in multinational pharmaceutical companies or top biotech firms. Required Skills Profound biological knowledge in core disease areas such as oncology, metabolism, autoimmunity, or the central nervous system. Deep understanding of emerging therapeutic modalities. Complete R&D success experience from the laboratory to the clinic. Led and advanced at least five innovative drug projects into the clinical stage and successfully completed POC. Outstanding scientific insight and strategic decision-making ability to predict industry trends and transform them into the company's R&D advantages. Outstanding leadership with the charisma and influence to inspire, attract, and retain top scientific talents. Preferred Skills Experience in establishing and managing global R&D teams. Strong network within the academic and biotechnology communities. Pay range and compensation package Competitive salary and comprehensive benefits package commensurate with experience. Chief Scientific Officer Early Drug Development • Boston, MA#J-18808-Ljbffr

Created: 2026-02-21